Illumina, Inc. ILMN recently introduced its second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system — NextSeq 550Dx. The instrument has been designed to deliver the power of ...
Both FDA-regulated and CE-in vitro diagnostic (IVD) marked, the NextSeq 550Dx instrument enables clinical laboratories to develop and perform a wide range of applications, from NGS IVD assays using ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
* Illumina Inc - introduction of its NextSeq 550Dx instrument, co's second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system Sign up here. * Illumina Inc - announced that ...
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today ...
TORONTO, March 16, 2021 /PRNewswire/ - Next-generation sequencing (NGS)-based precision oncology provider Geneseeq Technology Inc. ("Geneseeq"), will collaborate with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results